Prognosis of patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative, 1-3 node-positive breast cancer meeting the high-risk criteria of the monarchE trial: a comparison between macrometastasis and micrometastasis.

Breast Cancer · 2026 · PMC13283138 · PMID 42176177

Europe PMC DOI

hedged sentence

0.0510

closest p · 1.0× alpha

0.0510

boldest claim

The sentences

showed a trendp = 0.051so close (0.05 < p ≤ 0.1)

For tumor size, pT2 compared with pT1 showed a significant association (hazard ratio 2.39, 95% CI 1.15–13.0, p = 0.028), while pT3 compared with pT1 showed a trend toward an association (hazard ratio 2.45, 95% CI 1.00–13.6, p = 0.051).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.